Results 11 to 20 of about 3,598,260 (304)
Acknowledgment to Reviewers of Marine Drugs in 2020
Peer review is the driving force of journal development, and reviewers are gatekeepers who ensure that Marine Drugs maintains its standards for the high quality of its published papers [...]
Marine Drugs Editorial Office
doaj +2 more sources
Acknowledgement to Reviewers of Marine Drugs in 2013
The editors of Marine Drugs would like to express their sincere gratitude to the following reviewers for assessing manuscripts in ...
Marine Drugs Editorial Office
doaj +2 more sources
Acknowledgement to Reviewers of Marine Drugs in 2015
The editors of Marine Drugs would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2015. [...]
Marine Drugs Editorial Office
doaj +2 more sources
Acknowledgement to Reviewers of Marine Drugs in 2014
The editors of Marine Drugs would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2014:[...]
Marine Drugs Editorial Office
doaj +2 more sources
Acknowledgement to Reviewers of Marine Drugs in 2016
The editors of Marine Drugs would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2016. [...]
Marine Drugs Editorial Office
doaj +2 more sources
The present review discusses the effects of pharmaceutical drugs on aquatic ecosystem, in particular the fish to be precise. The focus is on roles of multiple drug types like antimicrobial, antipsychotic, analgesic, and anti-inflammatory; and the ...
Drugs and Fish
doaj +1 more source
Acknowledgment to the Reviewers of Marine Drugs in 2022
High-quality academic publishing is built on rigorous peer review [...]
Marine Drugs Editorial Office
doaj +1 more source
Acknowledgment to Reviewers of Marine Drugs in 2021
Rigorous peer-reviews are the basis of high-quality academic publishing [...]
Marine Drugs Editorial Office
doaj +1 more source
Drugging Drug Resistance [PDF]
Resistance to anticancer drugs is widely observed in vitro and in cancer patients, but its prevalence is too high to be solely explained by the acquisition of mutations. Sharma et al. (2010) now report that dynamic chromatin modifications may be an independent route to drug resistance in cancer cells that can be reversed by epigenetic drugs.
Dannenberg, Jan-Hermen, Berns, Anton
openaire +2 more sources
Impact of COVID-19 on drug markets, use, harms and drug services in Europe
Since early 2020, the COVID-19 pandemic has had a dramatic impact on the way we live, with European countries having to introduce unprecedented measures to protect public health. As with all areas of life, drug consumption, related harms and drug markets
Alessandro Pirona +12 more
doaj +1 more source

